Ophthalmology

Key opinion leaders discuss faricimab, its impact on the treatment landscape for wet AMD/DME, and what payers should look for when considering formulary positioning or utilization-management strategies.

Dr Coney discusses the variability of frequency dosing with anti-VEGF therapy in patients with wet AMD and DME, and Dr Sheth expands on Ang-2 and its contribution to the development of vascular instability in wet AMD.

A review found that visual impairment is common in older adults with dementia and associated with negative effects.

Geographic atrophy is a leading cause of blindness. The new approval will help to fill an unmet need for patients.

Dr Sheth discusses his insights on anti-VEGF therapy that he has noticed in the treatment of wet AMD over the last decade, and Caesar Luo, MD, FASRS, FACS shares his insight on new treatment options and their impact on patient access and cost considerations.

Dr Coney and Veeral Sheth, MD, MBA, FACS, FASRS, discuss treatment selection, treatment goals, and unmet needs for patients diagnosed with wet AMD and DME.

A nightly use of 0.05% atropine eyedrops resulted in a lower incidence of myopia compared with placebo.

Michael N. Cohen, MD, FAAO, retinal surgeon at Wills Eye Hospital in Philadephia and Mid Atlantic Retina, speaks about the future of gene therapy and the accessibility and availability of these therapies moving forward.

Joseph Coney, MD, FASRS, FACS, discusses the difference between population groups in age-related macular degeneration (AMD) and diabetic macular edema (DME)

Disparities in access to pediatric ophthalmological care is associated with lower socioeconomic status.

A recent study has found that the prevalence of vision impairment in US adults 71 years and older was higher in 2021 compared with prior estimates.

Retinal nerve fiber layer (RNFL) thickness has been independently associated with incident cardiovascular disease risks in a new analysis that utilized data from 2 international databases.

Patients who took hydroxychloroquine had an overall risk of hydroxychloroquine retinopathy of 8.6% after 15 years.

Retinal vasculature in peripheral regions of the retina differed in patients with Alzheimer dementia and mild cognitive impairment.

Diagnosing ocular surface diseases could be made easier as artificial intelligence (AI) screening improves.

A clinical trial found that the prevalence of age-related macular degeneration (AMD) was not associated with the use of metformin.

The top 5 most-read content in ophthalmology for 2022 focused on the relationship between aging and visual field reliability, telehealth eye care visits, the link between COVID-19 and dry eye disease, and more.

Coverage of the annual meeting of the American Academy of Ophthalmology (AAO) included interviews with experts on thyroid eye disease and anti–vascular endothelial growth factor therapy, as well as breaking research.

A new study has found that prolonged screen time may cause increased symptoms of dry eye disease (DED) in children.

A retrospective cohort study found that rapid thinning of the ganglion cell complex was associated with central visual field decline.

Meibomian gland dysfunction, an etiological factor of dry eye disease, showed promising results in response to treatment with intense pulsed light.

The risk of age-related macular degeneration (AMD) could be linked to structural variations in the APOE gene that were previously found to be associated with protection against Alzheimer disease.

A report from the World Health Organization highlights the global burden of oral diseases; study shows the predictive value of a “good” cholesterol level varies between Black and White patients; CDC report suggests people with impaired vision are not receiving proper health care.

A study found that dry eye disease (DED) can be separated into 5 subtypes, all of which differed significantly.

A recent study found that patients who had cataract surgery were satisfied overall with discharge teaching quality, were well prepared for discharge, and had good postdischarge outcomes.